RPRX Competitors & Alternatives
Compare Royalty Pharma Plc with similar stocks in the same industry
Biotechnology
RPRX
Main Stock$55.94
Tradestie Score
58
Market Cap
$15.70B
P/E Ratio
29.7
Revenue Growth
0.1%
Analyst Upside
+5.9%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$868.94
|
$46.96B | 38.9 | 56 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$305.12
|
$36.81B | 67.6 | 54 | Compare |
|
INSM
Insmed, Inc.
|
$109.44
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$89.52
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.59
|
$19.56B | 22.1 | 59 | Compare |
|
INCY
Incyte Genomics Inc
|
$113.58
|
$16.93B | 16.5 | 57 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.32
|
$15.22B | - | 53 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$267.71
|
$12.36B | 31.3 | 61 | Compare |
|
EXEL
Exelixis Inc
|
$55.55
|
$11.09B | 18.7 | 68 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.84
|
$10.76B | - | 67 | Compare |
More RPRX Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry